Job Description and Person Specification
Posts Academic Clinical Lecturership in Immunology or Clinical Oncology or Medical Oncology There is one NIHR funded post available in this round but additional locally funded posts may be awarded in parallel subject to funding and assessment against the stated criteria for the role
Department (s) Nuffield Department of Medicine, Henry Wellcome Building for Molecular Physiology, Old Road Campus, Headington, Oxford OX3 7BN Department of Oncology, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ
Division Medical Sciences Division
Contract type Fixed term for four years
Salary Grade A63 or A67: £33,790 - £59,765 per annum dependent on qualifications and experience, in line with current pay protection and transitional arrangements in the NHS
Overview of the post The University of Oxford is able to offer a number of Academic Clinical Lecturerships annually to suitably qualified applicants. These posts have been awarded by the NIHR to University/Deanery/NHS Trust partnerships nationally. They form part of the NIHR Integrated Training Pathway, further details of which can be found on the NIHR website http://www.nihr.ac.uk/IAT The Academic Clinical Lecturership is the final phase of the Integrated Academic Training Pathway. The posts are designed to allow time to complete a period of post-doctoral research to enable progress towards an independent academic career whilst completing clinical training. Applicants for these posts will be Specialist Trainees who have completed or have submitted for a higher degree (PhD / DPhil / MD). Oxford has a successful clinical academic programme delivered by the Oxford University Clinical Academic Graduate School in which all joint clinical/academic trainees take part. For further information see http://www.oucags.ox.ac.uk/. There is a strong record of support for
1 Clinical Lecturers through access to internal funding for research training courses, consumables, and for technical/research nurse support for projects. Over the four years post holders, in discussion with the training committees and academic supervisors, will be able to undertake clinical duties in order to complete their clinical training. All Clinical Lecturers are awarded an NTN (a). Post holders will be expected to spend 50% of their time (averaged over four years) on clinical duties and 50% on post-doctoral research. The appointment will be for a fixed term of four years. However, if training is completed during the four years the appointment will end six months after completion of CCT. Please see the NIHR Academic Clinical Lecturerships’ Entry, Eligibility, and Exit Points from April 2019 (annexed for full information). Applications are particularly welcome from women and black and minority ethnic candidates, who are under-represented in academic posts in Oxford. General queries about the post should be addressed Ms Heledd Gwilym at [email protected] or telephone: +44 01865 282342.
Informal enquiries can be made to: Immunology: Dr Siraj Misbah at [email protected] Clinical Oncology: Professor Mark Middleton at [email protected] Medical Oncology: Professor Mark Middleton at [email protected] All enquiries will be treated in strict confidence; they will not form part of the selection decision. The University of Oxford is a member of the Athena SWAN Charter to promote women in Science, Engineering, Technology and Medicine. The University holds an Athena SWAN bronze award at institutional level and both the Nuffield Department of Clinical Neurosciences and the Nuffield Department of Surgical Sciences holds a silver award. Contact [email protected] for further information about Athena SWAN at the University of Oxford.
Duties of the post
Immunology The Immunology programme will be based at the John Radcliffe Hospital in the Department of Immunology, an accredited and designated centre of clinical excellence for Clinical Immunology. TRAINING OBJECTIVES: 1. Successful application for a senior fellowship/award. The Lecturer will, under the supervision of a PI, design an appropriate research project, in translational immunology. The implementation of the work will enable acquisition of data suitable for an application for a senior fellowship award during year 3. 2. Continuation of the pursuit of an academic career: reviewing scientific papers, publication of pilot studies, submission to ethics committees and understanding advanced medical statistics. 3. Completion of training for CCT in Immunology, including success in FRCPath in Immunology (the exit examination for a CCT in Immunology). RESEARCH PROJECT: This will be undertaken under the supervision (as for a post-doctoral fellows) of a section leader in the Human Immunology Unit within the WIMM or The Nuffield Department of Medicine. Joint supervision is encouraged to facilitate translational research. The systemic functioning of immune
2 systems gives many opportunities for collaboration with organ-based specialists as well as clinician-scientists. The following principal investigators have offered translational projects: Dr Graham Ogg Prof Paul Klenerman Prof Lars Fugger Dr Sarosh Irani Prof Richard Cornall Prof Enzo Cerundulo Dr Smita Patel Dr Paul Bowness Prof David Jackson (Endothelial pathology) Prof Julian Knight . In addition, collaborations abroad (Karolinska Institute; Necker Hospital, Paris; University of Freiberg, National Institutes of Health, Bethesda) provide opportunities for secondment during a clinical training fellowship. Immunology services at the Oxford University Hospitals Foundation Trust: The Clinical Immunology Service covers the four counties of Berkshire, Buckinghamshire, Northamptonshire and Oxfordshire, making a population total of just under 3 million. The Department provides clinical and laboratory services to a population of 2.5million in the catchment area of the equivalent of the Thames Valley Strategic Health Authority. The NHS Department of Clinical Immunology provides a tertiary regional service to a population of ~1.4 million. It provides comprehensive treatment of immunological diseases, in particular primary and secondary immune deficiencies, systemic autoimmune disease and vasculitis (jointly with rheumatology) and complex allergies, including desensitisation immunotherapy. The department manages the Department of Health's demand management plan for Intravenous Immunoglobulin for a number of Trusts (OUH, Wexham Park, Milton Keynes GH, Buckinghamshire hospitals, Royal Berkshire Hospital) with one of the consultants designated as the lead. The department currently looks after 250 patients with primary antibody deficiency, 52 patients with C1 inhibitor deficiency, 50 patients with autoimmune neuropathies and 76 patients receiving desensitisation immunotherapy for insect venom allergy. The regional Immunology Laboratory, at the Churchill Hospital, provides a comprehensive diagnostic service. Clinical Immunology is accredited as a PID centre by UK Primary Immunodeficiency Network. The Laboratory is accredited by CPA (UK) Ltd and participates in all relevant EQA schemes. Immunology Clinics The post-holder will be closely involved in performing weekly clinics in Immunology and Allergy. In addition there are weekly paediatric infection and immunity, weekly venom desensitisation clinics, weekly drug allergy clinics, weekly connective tissue disease clinics and twice weekly immunoglobulin infusion clinics. Patients with primary immune deficiencies from the Central and South Central regions are seen in Oxford; there are no out-reach clinics. Ward referrals These consist of urgent requests for the assessment of children and adults with immunological diseases, for advice on diagnosis and /or management. These are covered by the consultants and junior clinical staff as appropriate. Access to inpatient beds for immunology patients is by arrangement with Infectious Diseases or the relevant organ-based specialty.
3 Oxford Immunology Service: the health professional team There are 3 consultant staff: Dr Siraj Misbah, Consultant Immunologist and Clinical Lead for Clinical Immunology Dr Smita Patel, Consultant Immunologist (Joint BRC-NHS appointment) Dr Rashmi Jain, Consultant Immunologist
ALLOCATION OF PROTECTED ACADEMIC TIME IN BLOCKS OVER FOUR YEARS:
Aim Year 1 Year 2 Year 3 year 4 Successful application for Senior Fellowship – protected time 26 26 24 22 Audit 0 6 4 4 Clinics 12 8 8 10 Secondments (e.g. Institute of Child Health) 0 0 6 6 Routine laboratory 8 6 4 4 Subtotal 46 46 46 46 Holidays 6 6 6 6 Total 52 52 52 52
This provides for 60 - 70% protected academic time in each of the four years, with a maximum early in the programme to enable the application to be made in the third year, in order to gain a senior fellowship. The CCT Immunology training will be completed in the last year. There is no on-call requirement for Immunology trainees, either academic or NHS.
Application for Senior Clinical Fellowship Award once training is completed Prior to the beginning the first year, candidates for clinical lectureships will be expected to have discussed intended projects with appropriate supervisors, to have visited the laboratory. There will be time early in the first year to submit an ethics application and to set up the collaborations required. Implementation of the project will then be part-time for the second half of year 1 and throughout years 2 & 3. Slightly less time has been allocated in years 3 & 4, whilst secondments (twice per week out of Oxford) are completed for training in London for haematopoetic stem cell transplantation for PIDs and advanced allergy.
Support for Training Fellowship/Award application In addition to help from the section leader in the research laboratory, the trainees will get full support from NDM administrative staff for their clinical training fellowship application. An independent academic supervisor will be identified for the duration of their Clinical Lectureship. This individual will work with the project & educational supervisors to monitor the progress of the Lecturer. An independent clinician from another, unrelated specialty would act as a mentor outside the academic remit of the programme.
4 THE QUALITY OF THE PROGRAMME will be maintained by: 1. Ensuring the high standard of entrants. Immunology is well established in Oxford and links with many collaborators in the UK around the world will enable recruitment of UK trainees to Oxford after their doctoral training elsewhere. 2. Regular appraisal of progress between the trainee and his/her educational supervisor as is obligatory for all trainees at present (usually 6 monthly) and will be used for Clinical Lecturers. 3. Annual ARCP for all academic and NHS trainees to include academic review - academic supervisor and educational supervisors together.
For further enquiries about research possibilities, candidates can contact Dr Siraj Misbah at ([email protected]) or Dr Smita Patel at ([email protected]).
Clinical Oncology The clinical aspect of the post would be tailored to meet the outstanding training needs of the successful applicant. We have significant experience in the department of meeting the needs of part time trainees and are able to offer all the required training within Oxford. There is a strong record of translational research and collaboration between the Clinical Oncology service and laboratories in the Oxford Institute for Radiation Oncology in ORCRB. There are research groups addressing radiosensitivity, tumour microenvironment and immunity, DNA repair as well as disease specific focus on colorectal, lung and pancreas cancers. The ACL post would be allied to one of these research groups or be able to continue with their own research programme, if established. Radiotherapy related research is based around the world leading Oxford Institute for Radiation Oncology which is located on the Old Road Campus immediately adjacent to the Churchill Hospital (https://www.radiationoncology.ox.ac.uk/). The Institute has approximately 200 research staff with state of the art facilities with opportunities for in vitro and in vivo investigation. Research themes within the Institute cover DNA damage response, Microenvironment, Immunity and metabolism as it affects response to radiation and clinical application. Preclinical targeted radiotherapy and imaging facilities located in the Radiation Research Institute is of outstanding quality. Full details of all group leaders and research facilities are available from the website.
The post holder will engage in advanced study or research and contribute through research activity, publication and securing external funding to maintaining the overall standard of the Institute. The post holder will spend at least 50% of time undertaking research over the duration of the contract. Typically this will be distributed in blocks (months) to allow concentrated time for research with fewer regular clinical commitments. The ACL will be expected to develop their own research programme related to Radiation Research or Clinical Oncology, which may be laboratory or clinically based and which is likely to be aligned to the interests of members of the Institute.
Medical Oncology The clinical aspect of the post would be tailored to meet the outstanding training needs of the successful applicant. We have significant experience in the department of meeting the needs of part time trainees, are able to offer all the required training within Oxford and have an excellent track record in developing our Clinical Lecturers along the academic career path. Translational research is a particular strength, with established units developing and delivering clinical trials and experimental research projects in the CRUK Centre, with the NIHR Biomedical 5 Research Centre and the Experimental Cancer Medicine Centre. There is a strong record of collaboration between the Medical Oncology service and laboratories at the Weatherall Institute for Molecular Medicine, Wellcome Trust Centre for Human Genetics, Target Discovery Institute, Big Data Institute and the many groups hosted on the Old Road Campus. There are research groups addressing angiogenesis, cancer genetics, immunology, cell signalling, growth factors, genome integrity, RNA biology, DNA repair and the cell cycle. The ACL post would be allied to one of these research groups or be able to continue with their own research programme, if established. The post holder will spend at least 50% of time undertaking research over the duration of the contract. Typically this will be distributed in blocks (months) to allow concentrated time for research with minimal regular clinical commitments. The ACL will be expected to develop their own research programme related to Medical Oncology, with an emphasis on acquiring the skills to flourish as an independent clinician scientist.
Training Environment for Clinical and Medical Oncology All trainees are allocated an educational supervisor for the full duration of training. CLs will in addition have an academic supervisor. CLs have regular appraisal sessions with their educational and academic supervisors, and an annual ARCP (to review clinical and academic progress) usually held in July. Guidance and encouragement will be given to help the post holder in applying for start-up funding (e.g. the Academy of Medical Sciences ‘Starter Grants for Clinical Lecturers’ scheme) and supporting you in your career aims especially in obtaining clinical scientist fellowship at the end of your ACL post. Regular weekly teaching sessions include the Department of Oncology’s internal and external weekly seminar programme as well as access to the University’s full range of courses. CLs also benefit from the support of the Oxford University Clinical Academic Graduate School.
Clinical Service The Oncology Directorate within the Oxford University Hospitals Trust comprises of 4 departments: Clinical Haematology (including Thrombosis and Haemophilia), Oncology (incorporating Clinical and Medical Oncology), Palliative Care and Medical Physics. The Oncology Department registers around 6000 new referrals a year, and provides patients with comprehensive care to include full assessment and treatment with both radiotherapy (3600 new patients, 42000 fractions) and chemotherapy (2200 new courses in OUH and 1300 new courses in DGHs). There are nearly 50 consultant oncologists (33 wte), and there is close integration between the NHS and University Departments of Oncology (Clinical Director Prof Bass Hassan and Head Prof Mark Middleton, respectively). All consultants (NHS and University, Clinical and Medical Oncology) have shared offices and secretarial support in the Cancer Centre grouped together in tumour site pods. For oncology there is an integrated ward of 26 beds for acute admissions (18), overnight chemotherapy admissions (4) along with 4 designated radiation protection beds. There is a linked 4 bed triage area, and 16 bed day case research area and laboratories to support the research. The nurse led triage service currently runs a 7 day service. There is a combined haematology and oncology outpatient area and chemotherapy suite. There is an integrated oncology department together with several university departments housed in the same building with the same facilities. An acute oncology service in the trust is provided by an acute oncology nurse on the JR site who coordinates the ward rounds in the JR. In addition, oncology consultants take part in a 1 in 21 consultant of the week rota cancelling all clinical commitments during their week (Monday 9am for 7 days) and undertaking a daily ward round on the Churchill site for all oncology patients and visiting the JR by request. The registrars take part in a 1 in 10 or 11 Registrar of the week rota working with the Consultant of the week. A variety of combined clinics are held at The Churchill and the John Radcliffe Hospitals including combined or parallel clinics for the management of lung, breast, haematological, endocrine, 6 dermatological, gynaecological and head and neck cancers, upper GI cancer amongst others. The Maggies Cancer Information Centre (CIC) is located in a new build adjacent to the cancer centre. The presence of the CIC on site facilitates the provision of a more holistic approach to care which the department is keen to see developed further.
Clinical trials The department of Oncology hosts the Oncology Clinical Trials Office (OCTO) which coordinates a portfolio of clinical trials, including a strong portfolio of radiotherapy and imaging studies. There are two large research teams supporting trial entry, the early phase team and the phase 3 team. Oxford is designated an Experimental Cancer Medicine Centre (lead Prof Sarah Blagden) and has an active academic and commercial first in human trials portfolio. A wide range of trials, including commercial studies are open across all tumour sites, with a heavy emphasis on early phase trials with translational end-points. Many of the studies are based around Oxford science and we are keen to develop this further.
For further enquiries about research possibilities in Medical or Clinical Oncology, candidates can contact Professor Mark Middleton ([email protected]).
Person specification Applications will be judged only against the criteria which are set out below. Applicants should make sure that their application shows very clearly how they believe that their skills and experience meet these criteria. Oxford is committed to fairness, consistency and transparency in selection decisions. Chairs of selection committees will be aware of the principles of equality of opportunity and fair selection and there will be a member of each gender wherever possible. The successful candidate will demonstrate the following: Essential Selection Criteria Eligibility: Evidence of achievement of Foundation competences or equivalent Medically qualified. At application, to hold or have submitted for a Higher Degree (PhD/MD/ DPhil) in a relevant subject area. At the time of starting the post (if appointed), the applicant must have completed the Higher Degree. See notes below* Evidence of good progress in clinical training and that completion of specialty training may be accommodated either during or after the 4 year period of the NIHR CL award. Candidate must be at ST3 or above and have more than one year to complete CCT. Knowledge and Achievements: Demonstration of acquisition of the level of knowledge and skills necessary for the achievement of Foundation and clinical (matched to the entry level) competencies or equivalent. Demonstration of understanding of, and commitment to, an academic career.
7 Demonstration of the potential for scientific independence and the ability to lead a research team. Potential to become a leader in the chosen field. Educational and Personal Aspects: Indication of medium and long-term career goals. Demonstration of educational reasons for applying for the Academic Clinical Lecturership Programme. Professional Skills: Evidence of team working skills. Evidence of leadership potential. Desirable Selection Criteria Evidence of commitment to GMC specialty and holding an NTN/NTN(A). Intercalated honours degree and/or additional qualifications e.g. MSc etc. Demonstrable commitment and career progression in the chosen specialty. Knowledge of Oxford and how this is best placed to support the research, education and training needs. Prizes or distinctions. Presentation of work at a national or international meeting. Significant publications in peer reviewed journals.
A detailed person specification by speciality, for higher specialty training as defined by MMC can be found at: http://specialtytraining.hee.nhs.uk/specialty-recruitment/person-specifications-2013/2016- person-specifications/
*Notes on Postgraduate Qualification: The NIHR Academic Clinical Lecturership phase is aimed at doctors and dentists who already hold a PhD/MD/DPhil (or equivalent) and who already have specialty training experience. It provides opportunities for post-higher degree research and facilitates applications for further research funding for doctors working towards completion of specialty training. The NIHR allows potential NIHR Clinical Lecturers to apply for the scheme before they have completed their postgraduate qualification although at the time of application they must have submitted their doctoral thesis. Under the 2019-20 scheme, a successful candidate must commence work before 31 March 2020 and, in order to take up a post, must have completed their PhD/DPhil/MD before their start date. To meet this criterion, the applicant should have been successfully examined. This means that the final examiner’s report has been signed off by their University, after approval of minor corrections. Successful candidates will be asked to supply a Degree Confirmation letter (or equivalent) as proof of completion, before a start date can be agreed and a contract issued. Please see the NIHR Academic Clinical Lecturerships’ Entry, Eligibility, and Exit Points from April 2019 (annexed for information).
How to apply To apply, visit www.ox.ac.uk/about/jobs/academic/index/ click on the relevant post title, then click on the Apply Now button on the ‘Job Details’ page and follow the on-screen instructions to register as
8 a new user or log-in if you have applied previously. Please refer to the “Terms of Use” in the left hand menu bar for information about privacy and data protection. Please provide details of two referees and indicate whether the University may contact them now.
You will be asked to upload a CV and an ACL application form. Please upload all documents as PDF files with your name and the document type in the filename.
You will also be asked to provide details of two referees and indicate whether the University may contact them now. You should contact both referees before applying to ensure that they are aware of the requirements for the post. The University will assume that it is free to approach referees at any stage unless the candidate’s application stipulates otherwise. Candidates who wish a referee or referees to be approached only with their specific permission and/or if they are being called for interview on the final shortlist or are in receipt of a conditional offer are asked to state such requirements specifically alongside the details of the relevant referee(s) on the application form.
Your application will be judged solely on the basis on how you demonstrate that you meet the selection criteria stated in the job description.
All applications must be received by 12.00 noon on 29 November 2019. Interviews are likely to be held on 13 December 2019.
Should you experience any difficulties using the online application system, please email [email protected]. Further help and support is available from www.ox.ac.uk/about_the_university/jobs/support/. To return to the online application at any stage, please go to: https://www.ox.ac.uk/about/jobs/.
All reasonable interview expenses will be reimbursed on receipt of a signed travel claim and valid receipts. The appointment will be subject to satisfactory completion of a medical questionnaire and the provision of proof of the right to work in the UK.
Important information for candidates
Pre-employment screening Please note that the appointment of the successful candidate will be subject to standard pre- employment screening, as applicable to the post. This will include right-to-work, proof of identity and references. We advise all applicants to read the candidate notes on the University’s pre- employment screening procedures, found at: www.ox.ac.uk/about/jobs/preemploymentscreening/.
Data Privacy Please note that any personal data submitted to the University as part of the job application process will be processed in accordance with the GDPR and related UK data protection legislation. For further information, please see the University’s Privacy Notice for Job Applicants at: www.admin.ox.ac.uk/councilsec/compliance/gdpr/privacynotices/job/. The University’s Policy on Data Protection is available at: www.admin.ox.ac.uk/councilsec/compliance/gdpr/universitypolicyondataprotection/.
The University’s policy on retirement The University operates an Employer Justified Retirement Age (EJRA) for all academic posts and some academic-related posts. From 1 October 2017, the University has adopted an EJRA of 30 September before the 69th birthday for all academic and academic-related staff in posts at grade 8 and above. The justification for this is explained at: www.admin.ox.ac.uk/personnel/end/retirement/acrelretire8+/. 9 For existing employees, any employment beyond the retirement age is subject to approval through the procedures: www.admin.ox.ac.uk/personnel/end/retirement/acrelretire8+/.
There is no normal or fixed age at which staff in posts at grades 1–7 have to retire. Staff at these grades may elect to retire in accordance with the rules of the applicable pension scheme, as may be amended from time to time.
Equality of Opportunity Entry into employment with the University and progression within employment will be determined only by personal merit and the application of criteria which are related to the duties of each particular post and the relevant salary structure. In all cases, ability to perform the job will be the primary consideration. No applicant or member of staff shall be discriminated against because of age, disability, gender reassignment, marriage or civil partnership, pregnancy or maternity, race, religion or belief, sex, or sexual orientation.
10 Essential Information for Applicants for the Academic Clinical Lecturership in Immunology or Clinical Oncology or Medical Oncology
The Departments
The Nuffield Department of Medicine hosts the Academic Clinical Lectureship in Immunology
The Nuffield Department of Clinical Medicine (NDM) is one of the largest departments of the University of Oxford and is part of the Medical Sciences Division, with responsibility for a significant part of the teaching of clinical students within the Medical School. The Department also has a substantial research programme which requires high quality administrative management. For this purpose, the Department is split into six groupings, with the Experimental Medicine unit forming one of these groups. NDM has significant financial turnover and complexity, resulting from its diverse research portfolio, its geographical spread and its close links with NHS funding and strategic teams involved in the development and delivery of increasingly integrated clinical research platforms. For more information please visit: http://www.ndm.ox.ac.uk/home
The Department of Oncology hosts the Academic Clinical Lecturership in Clinical Oncology and the Academic Clinical Lecturership in Medical Oncology
The Department of Oncology has over 400 staff and graduate students, and is one of the largest departments in the Medical Sciences Division. It has activities on four sites: the Old Road Campus Research Building, the Weatherall Institute of Molecular Medicine, the Radiobiology Research Institute, and the Oxford Cancer Hospital. The aim of the Department is the development of multidisciplinary and collaborative oncology research and it provides the translational hub for cancer research in Oxford. Working closely with colleagues in the new state-of-the-art NHS Oxford Cancer and Haematology Centre with the incorporated Radiotherapy Department, research can be rapidly and efficiently translated into cutting-edge clinical treatment for cancer patients. For more information please visit: http://www.oncology.ox.ac.uk
The University The University of Oxford aims to sustain excellence in every area of its teaching and research, and to maintain and develop its position as a leader amongst world-class universities. Placing an equally high value on research and on teaching, the colleges, departments and faculties of Oxford aspire both to lead the international research agenda and to offer a unique and exceptional education to our undergraduate and graduate students. Oxford’s self-governing community of scholars includes university professors, readers, and associate professors, college tutors, senior and junior research fellows and over 2,500 other university research staff. The University aims to provide facilities and support for colleagues to pursue innovative research and outstanding teaching, by responding to developments in the intellectual environment and society at large, and by forging close links with the wider academic world, the professions, industry and commerce The Strategic Plan, detailing strategy for the period 2013-18, can be found at http://www.admin.ox.ac.uk/pras/planning/. . Research at Oxford combines disciplinary depth with an increasing focus on inter-disciplinary and multi-disciplinary activities addressing a rich and diverse range of issues, from deciphering ancient
11 texts and inscriptions using modern scientific and computational methods developed in Oxford, through to global health, climate change, ageing, energy and the effects on our world of rapid technological change. Oxford seeks to admit undergraduate students with the intellectual potential to benefit fully from the college tutorial system and small group learning to which Oxford is deeply committed. Meeting in small groups with their tutor, undergraduates are exposed to rigorous scholarly challenge and learn to develop their critical thinking, their ability to articulate their views with clarity, and their personal and intellectual confidence. They receive a high level of personal attention from leading academics. Oxford has a strong postgraduate student body which now numbers nearly 10,000, nearly 45% of the full-time students. Postgraduates are attracted to Oxford by the international standing of the faculty, by the rigorous intellectual training on offer, by the excellent research and laboratory facilities available, and by the resources of the museums and libraries, including one of the world’s greatest libraries, the Bodleian. For more information please visit www.ox.ac.uk
The Medical Sciences Division The Medical Sciences Division is an internationally recognized centre of excellence for biomedical and clinical research and teaching. We are the largest academic division in the University of Oxford. World-leading programmes, housed in state-of-the-art facilities, cover the full range of scientific endeavour from the molecule to the population. With our NHS partners we also foster the highest possible standards in patient care. For more information please visit: www.medsci.ox.ac.uk
Oxford University Hospitals NHS Foundation Trust Oxford University Hospitals (OUH) is a world renowned centre of clinical excellence and one of the largest NHS teaching trusts in the UK. Clinical care is delivered by experienced specialists at the pinnacle of their profession. Our trust is made up of four hospitals - the John Radcliffe Hospital (which also includes the Children's Hospital and West Wing), Churchill Hospital and the Nuffield Orthopaedic Centre, all located in Oxford and the Horton General Hospital in the north of Oxfordshire. We provide a wide range of clinical services, specialist services (including cardiac, cancer, musculoskeletal and neurological rehabilitation) medical education, training and research. Our collaboration with the University of Oxford underpins the quality of the care that is provided to patients; to the delivery of high-quality research bringing innovation from the laboratory bench to the bedside; and the delivery of high-quality education and training of doctors. Existing collaborations include the ambitious research programmes established through the Oxford Biomedical Research Centre (BRC), funded by the National Institute for Health Research (NIHR), located on the John Radcliffe Hospital site and at the Biomedical Research Unit in musculoskeletal disease at the Nuffield Orthopaedic Centre. These set the standard in translating science and research into new and better NHS clinical care. For more information on the Trust and its services visit http://www.ouh.nhs.uk/
12 University Benefits, Terms and Conditions
Salary The salary for the Academic Clinical Lecturer will be confirmed according to qualifications and experience and where necessary in line with current pay protection arrangements in the NHS. Pension The University offers generous pension provision. Eligible staff may join the Universities Superannuation Scheme (http://www.admin.ox.ac.uk/finance/pensions/uss/) or the National Health Service Superannuation Scheme (http://www.nhsbsa.nhs.uk/pensions).
Length of appointment The appointment will be for a fixed term of four years. However, the appointment will end after four years or six months after completion of CCT, whichever is earlier. The appointment will be reviewed formally at the end of a probationary period of 24 months following a report requested after 18 months in post. The length of appointment for local posts will depend on the funding available.
Outside commitments Academic clinical lecturers may spend up to 30 working days in each year on projects outside their employment duties, such as consultancy, spin-out activity and membership of research councils and other bodies. There is no limit to the amount of money which staff may earn from these activities. Full details are available on the university website at http://www.admin.ox.ac.uk/personnel/staffinfo/academic/approvaltoholdoutsideappointments/. Guidance on ownership of intellectual property (http://www.admin.ox.ac.uk/statutes/regulations/182-052.shtml) and managing conflicts of interest (http://www.admin.ox.ac.uk/researchsupport/integrity/conflict/policy/) is also available on the university website.
Medical Defence Society Although it is not a condition of employment that academic clinical lecturers belong to a medical defence society, it is strongly recommended that such staff maintain at least the basic cover provided by such bodies.
Membership of Congregation Oxford’s community of scholars governs itself through Congregation which is its “parliament”. You will be a voting member of Congregation.
See www.ox.ac.uk/about/organisation/governance and www.admin.ox.ac.uk/statutes/781- 121.shtml for further details.
13 Family support
The University offers generous family leave arrangements, such as maternity, adoption, paternity and shared parental leave. Details are available at www.admin.ox.ac.uk/personnel/during/family/. You will have considerable flexibility in the day-to-day organisation of duties in the Associate Professor role. Requests for flexible working patterns will be accommodated as far as possible.
You will be eligible to apply to use the University nurseries (subject to availability of places). For details of the nurseries and how to apply for places, please see www.admin.ox.ac.uk/childcare/.
The University subscribes to My Family Care, a benefit which allows staff to register for emergency back-up childcare and adultcare services, a 'speak to an expert' phone line and a wide range of guides and webinars through a website called the Work + Family Space.
For more details, please see www.admin.ox.ac.uk/personnel/staffinfo/benefits/family/mfc/
The Oxford University Newcomers' Club is run by volunteers, whose aim is to help the newly-arrived partners of visiting scholars, of graduate students and of newly appointed academic and administrative members of the University to settle in and to give them opportunities to meet people in Oxford. Further information is available at www.newcomers.ox.ac.uk/.
The Careers Service has a dedicated adviser for the partners of University employees, offering assistance in finding employment, training or volunteering opportunities.
For details, please see www.careers.ox.ac.uk/
Welcome for International Staff
One of Oxford’s great strengths is its truly international body of research and teaching staff from over 140 countries, and we welcome applications from academics across the world. We can help international staff and partners/families make the transition to Oxford. Information about relocation, living and working in the UK and Oxford is available at www.internationalstaffwelcome.admin.ox.ac.uk/
If you require a visa, we have a dedicated team to support successful applicants through the immigration process (for Tier 1 and Tier 2 visas) from job offer through to arrival in the UK.
Promoting diversity
The University is committed to recruiting and retaining the best people, whoever they are, to ensure equality of opportunity. The Vice Chancellor’s Diversity Fund provides resources for innovative projects to promote diversity.
The Equality and Diversity Unit promotes good practice across the University by developing policies and offering training, and runs a range of support networks for staff. It works closely with Colleges, the Oxford University Student Union and external campaign groups. Please see www.admin.ox.ac.uk/eop/ for details.
14 Other benefits and discounts for University employees
The University has a range of facilities and benefits for its staff, including discounted health insurance, sustainable travel schemes, and discounts in local shops and restaurants. Details are available at: www.admin.ox.ac.uk/personnel/staffinfo/benefits/ www.admin.ox.ac.uk/personnel/staffinfo/discountsforstaff/services/
Pre-employment screening
The appointment of the successful candidate will be subject to the University’s standard pre- employment screening. This will include right-to-work, proof of identity, references, a pre- employment health declaration, and any other checks as applicable to the post. We advise you to read the notes for applicants at www.ox.ac.uk/about/jobs/preemploymentscreening/
Immunity status, medical declaration and appraisal
NHS Trusts will not allow honorary contract holders to commence clinical contact with patients unless documentary evidence is produced of Hepatitis B status, BCG vaccination/TB immunity, and Rubella immunity. The successful candidate will therefore be required to produce such documentary evidence. The appointment will also be subject to satisfactory completion of a University medical declaration and an NHS pre-employment assessment form
The Academic Clinical Lecturer will be required to take part in the relevant NHS appraisal scheme.
Offer of employment
Applications for this post will be considered by a selection committee containing representatives from the relevant department, the OUHFT, TVHEE and OUCAGS. The selection committee is responsible for conducting all aspects of the recruitment and selection process; it does not, however, have the authority to make the final decision as to who should be appointed. The final decision will be made by the Medical Sciences Divisional Board on the basis of a recommendation made by the selection committee. No offer of appointment will be valid, therefore, until and unless the recommendation has been approved by the divisional board, and a formal contractual offer has been made.
Hazard-specific / Safety-critical This job may include the following hazards or safety-critical activities which will require successful pre-employment health screening through our Occupational Health Service before the successful candidate will be allowed to start work:
Night working (11pm-6am) Lone Working Working with Ionising Radiation Working with category 3b or 4 lasers (laser safety class) Working with infectious pathogens (hazard group 2/3) - Hazard Group 3 pathogens Working with blood, human products and human tissues Work in clinical areas with direct contact with patients (NOT administrative roles) Work with allergens, E.g. laboratory animals, pollen, dust, fish or insects etc.
15 Work with any substance which has any of the following pictograms on their MSDS:
Travel outside of Europe or North America on University Business
Additional security pre-employment checks
A satisfactory Disclosure and Barring Service check due to regulated activity involving children OR regulated activity involving ‘at risk’ adults University security screening (e.g. identity checks)
16 NIHR Clinical Lecturerships: Entry, Eligibility, and Exit Points from April 2019
INTRODUCTION This guidance note relates to the recruitment of NIHR Clinical Lecturerships (CLs) starting on or after 1st April 2019. Successful applicants from the 2019 recruitment round must be in post by 31st March 2020. The NIHR Clinical Lecturership phase is aimed at doctors with a PhD/MD (or equivalent) in a relevant subject area, who already have a substantial amount of specialty training experience. It provides opportunities for post-higher degree research and facilitates applications for further research funding for doctors working towards completion of specialty training. APPRAISAL There should be joint academic and clinical appraisal according to Follett principles with assessment, according to College and LETB recommendations for Clinical Lecturers. A general overview for reviewing the progression of trainees undertaking joint clinical and academic training programmes is provided in the Gold Guide, though to aid trainees, supervisors and assessors in reviewing academic training and progress, the Academy of Medical Sciences has formulated supplementary guidelines available at: http://issuu.com/acmedsci/docs/guidelin/1 ENTRY The NIHR Clinical Lecturer post is aimed at doctors who must already hold a higher research degree (MD/PhD or equivalent) in a relevant subject area.
The 4-year duration of the NIHR Clinical Lecturership may mean that a period of dedicated clinical training is appropriate. This may be taken prior to application, in which case the candidate will become ineligible for a 2019 post, if the length of their dedicated period of clinical training would preclude them from applying and taking up the NIHR Clinical Lecturership before the 31st March 2020 deadline. It may, in some cases, be more appropriate to undertake a period of clinical training upon completion of the NIHR Clinical Lecturership. This must be taken into account by the individual and his/her Training Programme Director and the appropriate arrangements put in place to accommodate this.
NIHR Clinical Lecturerships are designed for those that have already had a substantial period of clinical training, therefore appointments may not be made at FY2, CMT, CST, ST1 or ST2. NIHR Clinical Lecturership posts may only be offered at ST3 or above.
Individuals who are successful at interview must be able to take up their post before 31st March 2020. No extensions will be granted.
17 ELIGIBILITY Doctors wishing to apply for a NIHR CL must already hold a higher research degree (PhD, MD, or equivalent) in a relevant subject area and must be at a minimum level of ST3. NIHR CLs are designed for those who have made satisfactory progress in both clinical and academic training. Trainees will have completed Foundation Training (or equivalent) and will have already had a substantial period of clinical training; therefore appointments may not be made at FY2, CMT, CST, ST1, or ST2. Specialist Registrars (SpR) or Specialty Registrars (StR) may apply to this scheme. Doctors with specialist/ty experience (as an SHO, LAT or equivalent), who meet the entry criteria into specialty training may also apply, subject to them having completed a relevant PhD, MD, or equivalent. The scheme is open to general practitioners (GPs) who have completed a PhD, MD, or equivalent and have completed their clinical training. Exceptional candidates nearing the end of their vocational training may also be considered. NIHR CL posts are only available to medically-qualified candidates. Non-medical healthcare professions should reference the HEE/NIHR Integrated Clinical Academic (ICA) Programme. Candidates that have already completed one NIHR CL may not apply for another, but may apply for a locally-funded Clinical Lectureship. Candidates with less than 1 year to gaining a Certificate of Completion of Training (CCT) may be more suited to a NIHR Advanced Fellowship, or other post-doctoral fellowship, rather than a NIHR CL. Candidates may only apply if they have already submitted their PhD or MD thesis at the time of application. If the candidate’s thesis has not been submitted by the application closing date, then they are ineligible to apply in this round. Successful candidates may not take up their post until their PhD or MD had been fully awarded. If this will not be awarded until after the 31 March 2020 deadline, then the candidate is ineligible to apply in the 2019 round. COMPLETION OF AN NIHR CLINICAL LECTURERSHIP The duration of a NIHR CL will be for a maximum of 4 years (1.0 WTE) or until CCT is reached, whichever is the sooner. During this time the trainee combines 50% clinical specialty training with 50% academic training to complete a substantial piece of postdoctoral research. It is expected that a significant number of the trainees will, where appropriate, apply for a further peer reviewed, post-doctoral training award such as a NIHR Advanced Fellowship. For trainees who are not anticipated to reach CCT within the maximum 4 years funding of the NIHR CL post, arrangements will need to be put in place locally to enable the trainee to return to standard clinical training after the completion of the NIHR CL. Examples are shown below:
1. A trainee has been in post for 3 years and reaches CCT. The 6 month period of grace will apply and the maximum extension that can be granted will be a further 6 months. 2. A trainee has been in post for 18 months and reaches CCT. The 6 month period of grace will apply and the maximum extension that can be granted will be a further 12 months. Even though the 4 year maximum has not been reached, a maximum limit of a further 12 months for an extension will apply. 3. To discuss extensions further on a case by case basis, please contact [email protected].
For trainees who will not reach CCT within the maximum 4 years of the NIHR Clinical Lecturership post, arrangements will need to be put in place locally to enable the trainee to return to clinical training after the completion of the NIHR CL post and therefore reach CCT.
18 Clinical benchmarking guidance for Clinical Lectureship appointments where the applicant does not currently hold an NTN or NTN(A) in the associated Specialty
Introduction This document refers to the appointment of doctors to all Clinical Lectureship (CL) posts, including NIHR-funded CLs and those that are locally funded.
UK and EU trainees must already be in specialty training in order to be eligible for a CL. This requirement does not apply to non-UK, non-EU applicants. These constitute a small number and currently they are benchmarked against the specialty person specifications by the appointing university panel. The intention of this proposal is to formalise a more robust clinical benchmarking process for prospective non-UK, non-EU applicants to CL posts.
A. Benchmarking Process Applicants must be benchmarked clinically against the appropriate national person specifications for entering clinical training in the relevant specialty before appointment to the ACL post either by: 1. An application and interview at the usual entry point into the specialty concerned.
Or, in exceptional circumstances: 2. If the above is not feasible, then at the discretion of the local Postgraduate Dean, a special panel may be convened to clinically benchmark the applicant. This will be separate to any academically focussed university interview(s). It may however be feasible for this to take place on the same day to minimise the impact on the applicant.
B. Constitution of Panel The panel should consist of: 1. Representatives nominated by the Postgraduate Dean. These will usually be the Head of School and the specialty Training Programme Director (TPD). 2. A lay member. 3. A senior educator from a different deanery/local HEE office footprint, with recent experience in national selection, nominated by the Chair of the Specialty Advisory Committee (SAC), or equivalent. 4. Any other clinician necessary to ensure a robust process, equivalent to, and replicating that used in, national recruitment.
C. Assessment Process This should be against the national person specification (PS) for entry into the specialty. In many cases there will be no agreed PS for anything other than the usual entry point into the specialty, and if so, this should be used. If the panel as described above cannot be constituted for any reason, then benchmarking must be through the relevant national selection process.
D. Administration National or local benchmarking will be coordinated by the recruitment team in the local deanery/HEE office, in partnership with the local medical school academic training office, and the relevant national recruitment team.
E. Funding
19 The Postgraduate Dean will need to judge that the costs associated with constituting a local panel are fully justified, through clear evidence of an outstanding academic application that could not otherwise be benchmarked through national recruitment. These will be met by the partnership from within allocated NIHR administration and management funding. February 2019
20